FocalTherics™ Reports Third Quarter 2026 Financial Results

11/6/2026
Impact: 65
Healthcare

FocalTherics (formerly EDAP TMS S.A.) reported third-quarter 2026 revenue of $9.8 million, up 26% year over year, and gross margin of 51.4%, compared with 46.6% a year earlier. It sold seven Focal One capital systems and recorded a 32% year-over-year increase in U.S. procedure volume. The company narrowed its 2026 revenue guidance to $50 million–$52 million from $50 million–$54 million and ended the quarter with $56.3 million in cash and cash equivalents.

AI summary, not financial advice

Share: